Catherine J. Drummond

Auckland, AUK 1142, New Zealand

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Transdifferentiation of endothelial progenitor cells into rhabdomyosarcoma defined by hedgehog signaling competence.

Transdifferentiation of endothelial progenitor cells into rhabdomyosarcoma defined by hedgehog signaling competence.

Journal: Cell reports
Published: June 09, 2026

MicroRNA Mimics Based on the miR-15/107 Consensus Sequence Sensitise NSCLC Cells to Targeted Therapy.

MicroRNA Mimics Based on the miR-15/107 Consensus Sequence Sensitise NSCLC Cells to Targeted Therapy.

Journal: International journal of molecular sciences
Published: January 22, 2026

TP53 mutation at codon 179 metabolically reprograms cancer cells to promote invasion.

TP53 mutation at codon 179 metabolically reprograms cancer cells to promote invasion.

Journal: Cancer gene therapy
Published: July 30, 2025

Transdifferentiation of endothelial progenitor cells into rhabdomyosarcoma defined by hedgehog signaling competence.

Transdifferentiation of endothelial progenitor cells into rhabdomyosarcoma defined by hedgehog signaling competence.

Journal: Cell reports
Published: March 26, 2025

Δ133p53 isoform enhances TLR4 function to promote tumor growth.

Δ133p53 isoform enhances TLR4 function to promote tumor growth.

Journal: Carcinogenesis
Published: February 22, 2025

The Potential Links between lncRNAs and Drug Tolerance in Lung Adenocarcinoma.

The Potential Links between lncRNAs and Drug Tolerance in Lung Adenocarcinoma.

Journal: Genes
Published: May 31, 2024

Non-cell-autonomous tumor promotion in DICER1 cancer predisposition.

Non-cell-autonomous tumor promotion in DICER1 cancer predisposition.

Journal: Developmental cell
Published: May 30, 2024

Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage.

Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage.

Journal: Nature communications
Published: August 18, 2023

PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors.

PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors.

Journal: Nature communications
Published: December 12, 2022

Adaptive homeostasis and the p53 isoform network.

Adaptive homeostasis and the p53 isoform network.

Journal: EMBO reports
Published: April 18, 2021

Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity.

Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity.

Journal: Nature communications
Published: April 05, 2021

DNA-Binding Anticancer Drugs: One Target, Two Actions.

DNA-Binding Anticancer Drugs: One Target, Two Actions.

Journal: Molecules (Basel, Switzerland)
Published: December 26, 2020
Showing 1-12 of 24

Last Updated: 09/26/2026